Becker Kimberly, Saad Maha
St. John's University, Jamaica, NY, USA.
Adv Ther. 2017 Apr;34(4):848-853. doi: 10.1007/s12325-017-0508-9. Epub 2017 Mar 13.
This article informs the reader of the current information available on a novel therapeutic agent and new class of drug for the treatment of anemia. The data show promising results for alternative erythropoietin-stimulating agents and offers a time line of when Phase III data will be available. The information on this new drug and new drug class will change how nephrologists approach treating anemia within their patients.
本文向读者介绍了一种用于治疗贫血的新型治疗药物及新一类药物的现有信息。数据显示替代促红细胞生成素刺激剂取得了有前景的结果，并给出了三期数据将公布的时间线。关于这种新药及新一类药物的信息将改变肾病学家治疗患者贫血的方式。
